Advertisement

Topics

Megamedics GmbH Company Profile

14:42 EST 18th November 2017 | BioPortfolio

Megamedics is a young life science company active in the challenging area of functional proteomics. The company applies the proprietary FITT™ technology for the development of innovative products suitable for treatment and diagnosis of prevalent types of cancer. The strategy used to discover tumor-specific target molecules involves a unique combination of cell biological, immunological and proteomic techniques. The function-based methodology for target identification and validation enables a rapid assessment of their specificity and suitability as therapeutic or diagnostic tools in oncology.

Beyond the own R&D programs Megamedics offers various custom services in the field of protein analytics to industry and academic institutions. The available techniques comprise state of the art mass spectrometry as well as high throughput methods for separation and processing of proteins. Owing to our advanced infrastructure and the extensive research experience of our scientists, Megamedics provides highest possible precision and reliability for advanced proteomics projects.



Megamedics is currently expanding its network with partners and customers to accelerate the business development process. In particular we seek collaborations and alliances with pharma and biotech companies on drug discovery and development.

Location

Hafenstrasse 32
Wedel
D-22880
Germany

Contact

Phone: +49- (0)4103- 98 90 50
Fax: +49- (0)4103- 98 90 60
Email: marti@megamedics.com


News Articles [118 Associated News Articles listed on BioPortfolio]

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Endocyte licenses radioligand prostate cancer therapy from ABX GMBH

Endocyte Inc. received exclusive global rights to the radioligand therapeutic PSMA617 (177LuPSMA617) from ABX GMBH.

DGAP-News: GBC Kapital GmbH: Erfolgreich abgeschlossene Kapitalmaßnahme der SYGNIS AG - beide Kapitalerhöhungen wurden von der GBC Kapital GmbH und der MC Services AG, jeweils als Co-Lead Manager Institutional Sales, begleitet und waren signifikant

GBC Kapital GmbH: Erfolgreich abgeschlossene Kapitalmaßnahme der SYGNIS AG - beide Kapitalerhöhungen wurden von der GBC Kapital GmbH und der MC Services AG, jeweils als Co-Lead Manager Institution.....

Körber Plans Takeover of Systec Services GmbH

     (Photo: http://mma.prnewswire.com/media/558312/SystecServices_Headquarters.jpg) With the planned takeover, Körber Medipak Systems GmbH, the holding company of Business Area Pharma Systems...

Original-Research: Valneva SE (von First Berlin Equity Research GmbH): BUY

Original-Research: Valneva SE - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Valneva SE Unternehmen: Valneva SE ISIN: FR0004056851 Anlass der Studie: U...

SyncDog Secures Distributor Partner Agreement with Germany-based EBF GmbH for EBF Migrator, EBF’s Platform for Accelerating EMM Migrations

Reston, VA (PRWEB) September 26, 2017 SyncDog, Inc. , the leading ISV for mobile application security, today announced a distributo...

Rentschler Biotechnologie GmbH transforms into European corporation

Rentschler Biotechnologie GmbH announced that the Company has successfully transitioned into a European corporation (SE) with entry into the German commercial register on October 1, 2017. The Company ...

Pharmaceutical Packaging Equipment Market - Demand for Patient...

Majority share in the global pharmaceutical packaging market is held by the leading five companies, rendering its vendor landscape consolidated. These companies are IMA S.P.A, Robert Bosch GmbH, Korbe...

PubMed Articles [15 Associated PubMed Articles listed on BioPortfolio]

Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.

To evaluate safety (primary objective) and efficacy of increasing doses (400 U up to 800 U) of incobotulinumtoxinA (Xeomin, Merz Pharmaceuticals GmbH) for patients with limb spasticity.

Biomechanical Characterization of Subclinical Keratoconus Without Topographic or Tomographic Abnormalities.

To present a case series of patients with subclinical keratoconus with normal topometric (anterior curvature) and tomographic findings in one eye who showed abnormalities detected by Corvis ST (Oculus...

Pulled-out locking screw re-screwed spontaneously in anterior cervical decompression and fusion with the zero-profile implant system: A case report.

The zero-profile, standalone device (Zero-P, Synthes GmbH, Switzerland) has been reported to be an effective and safe treatment method with similar clinical outcomes compared with plate. Instrumental ...

Cyclic and Torsional Fatigue Resistance of Reciprocating Single Files Manufactured by Different Nickel-titanium Alloys.

The aim of this study was to evaluate the cyclic and torsional fatigue resistance of the following reciprocating single-file systems: ProDesign R 25.06 (Easy Equipamentos Odontológicos, Belo Horizont...

Reliability of a Skin Diagnostic Device in Assessing Hydration and Erythema.

To examine the reliability of a skin diagnostic device, the SD202 (Courage+Khazaka GmBH, Cologne, Germany), in assessing hydration and erythema of periwound skin and pressure injury-prone areas.

Clinical Trials [39 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Telemedical Examination of a Three-Component Oculomotor Testing Battery

The study investigates the feasibility and safety of the telemedical implementation of three diagnostic oculomotor tests using a video-oculography device and an extended teleconferencing s...

Influence of Non-invasive Neurostimulation (Transcutaneous Vagus Nerve Stimulation) on 1. the Noradrenergic Release in the Brain and 2. a Neuropsychological Memory Task

The goal of this study is to investigate the influence of transcutaneous vagus nerve stimulation 1. on the noradrenergic system in the brain and 2. on memory, in healthy volunteers. ...

Companies [524 Associated Companies listed on BioPortfolio]

Megamedics GmbH

Megamedics is a young life science company active in the challenging area of functional proteomics. The company applies the proprietary FITT™ technology for the development of innovative products su...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Praher Beteiligungs GmbH

The vision of the company founder Ludwig Praher to produce better and better products of high-grade plastics was the basis for sound growth. Under the direction of Ing. Winfried Praher and Ewald Prahe...

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...

More Information about "Megamedics GmbH" on BioPortfolio

We have published hundreds of Megamedics GmbH news stories on BioPortfolio along with dozens of Megamedics GmbH Clinical Trials and PubMed Articles about Megamedics GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Megamedics GmbH Companies in our database. You can also find out about relevant Megamedics GmbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record